Background: The role of claudin-1 in aggressiveness and increased metastatic phenotype is controversial issue in different cancers.
Introduction
BREAST cancer is the most common cancer and the second leading cau se of cancer death in women worldwide [1] . In Egypt, Cancer breast is the most common cancer among women, representing 18.9% of total cancer cases and 3 7.6% of female cancers [2] .
Breast cancer is a clinically highly heterogeneous disease with distinct pathological and histological features. Breast cancer is classified into different molecular subtypes that are often distinguished by immunohistochemical staining of the Estrogen Receptor (ER), Progesterone Receptor (PR), and HER2, along with Ki-67 staining [3] .
Tight Junctions (TJs) form the closes contacts between adjacent cells along the apical border of the epithelial cell membrane. They are involved in maintaining the architecture and functional integrity of the cell and linked to the machinery that controls apicobasal polarization [4] . Three types of integral membrane proteins constitute the tight junctions; the claudins, occludin and the junctional adhesion molecules [5] . claudin-1 is a transmembrane protein responsible for maintaining cellular polarity and playing major role in cell-cell communication and epithelial cell homeostasis [6] .
The interruption of TJ during tumorigenesis leads to invasiveness, loss of cohesion and lack of differentiation in tumor cells [7] . Claudin is involved in tumor progression by its important role in migration, invasion and metastasis of tumor cells.
Some studies have shown that they play a role in the Epithelial to Mesenchymal Transition (EMT) and in the formation of tumor stem cells or tumorinitiating cells (CSC/TIC), however the actual underlying mechanism remains uncertain [8] .
Claudin-1 expression is frequently altered in different types of cancer [9] . In some cancers as lung cancer and hepatocellular carcinoma, loss of claudin-1 has been linked to cancer progression and invasion, and the acquisition of the metastatic potential. Conversely, in other cancers, such as oral squamous cell carcinoma, gastric carcinoma and melanoma, over expression of claudin-1 has been associated with aggressiveness and increased metastatic phenotype [6] .
Ki-67 is a nuclear protein associated with cell proliferation. Nuclear antigen Ki-67 is expressed in certain phases of the cell cycle namely S, G1, G2 and M phases, but is not present in G0 [10] . Therefore, the proliferative activity determined by Ki-67 may reflect the aggressive behavior of breast cancer and predict the recurrence time and appropriate therapy required in treatment [11] .
The present study aimed to appreciate the correlation between claudin-1 and Ki-67 proliferative index in breast ductal carcinoma and evaluate their diagnostic role in differentiating between different molecular subtypes in addition to their correlation with the various definite clinical-pathological parameters including Nottingham Prognostic Index (NPI).
Patients and Methods
This is a retrospective study on 54 cases of female breast ductal carcinoma, (Invasive Carcinoma of No Special Type NST). Ten cases of benign breast lesions were taken as control. Archived formalin-fixed, paraffin embedded blocks of tumor specimens, were collected from Benha Pathology Department, Faculty of Medicine, Benha University and International Medical Center in the period from the years (2013-2016). The clinicopathological data concerning age of patients, tumor size, hormonal status and distant metastasis were collected from the files of patients after approval by the Ethical Committee at Faculty of Medicine, Benha University.
Histopathological study: Four-micron thick sections were stained by conventional hematoxylin and eosin (H & E) stain. Two blind expert pathologists independently confirmed histologic diagnosis of each lesion and grading.
Immunohistochemical study: For Immunohistochemical (IHC) staining, 10% formalin-fixed, paraffin-embedded, 4-micron tissue sections on positive slides were prepared. Immunostaining was applied for ER mouse monoclonal (1D5 ) antibody (Thermo Fisher scientific anatomical pathology, USA) prediluted ready to use, PR mouse monoclonal (Alpha PR6) antibody (Thermo Fisher scientific anatomical pathology, USA) prediluted ready to use, HER2 mouse monoclonal (3B5) antibody (Thermo Fisher scientific anatomical pathology, USA) prediluted ready to use, Ki-67 Rabbit polyclonal antibody (Thermo Fisher scientific anatomical pathology, USA) prediluted ready to use and claudin-1, Rabbit polyclonal antibody (Thermo Fisher scientific anatomical pathology, USA) prediluted ready to use. DAP was utilized as a chromogen. IHC staining was performed using Detection kit (Fremont, USA) according to the manufacturer's guidelines. Endocervical epithelium, endometrial tissue, gastric carcinoma, lymphoid tissue of tonsil and normal skin were used as positive control for ER, PR, HER2, Ki-67 and claudin-1, respectivelly. Negative control for all was achieved by omitting the primary antibody.
Interpretation of immunohistochemical staining:
ER: The expression was detected as nuclear staining. Percentages of ER expression were estimated from the entire tumor area. Nuclear Staining in >10% of tumor cells was considered positive.
PR:
The expression was detected as nuclear staining. Percentages of PR expression were estimated from the entire tumor area. Nuclear Staining in >10% of tumor cells was considered positive.
HER2: Strong, circumferential membranous staining in >30% of invasive carcinoma cells was scored as 3+; moderate, circumferential membranous staining in ≥ 10% of invasive tumor cells or 3+ staining in <_30% of cells was scored as 2+;
weak and incomplete membranous staining in invasive tumor cells was scored as 1+; and no staining was scored as 0. Tumors with 0 and 1+ staining were considered negative, cases scored as 2+ were considered equivocal, and cases with 3+ staining were considered positive.
Claudin-1:
The expression was detected as membranous and diffuses cytoplasmic staining. Immunoreactivity was assessed based on a combined score of extent and intensity of staining. Scores 0-3 were assigned according to the percentage of positive tumor cells (0=0%; 1=<25%; 2=25-50%; 3=>51%) and the intensity of staining in tumor (0=0; 1=1+; 2=2+; 3=3+). The two scores were multiplied to give an overall score of 0-9, of which 0 was considered negative, 1-2 weak, 3-6 moderate, and 9 strong staining. Negative and weak expression was considered as low, whereas moderate and strong as high [9] . By using Roc curve, the optimal cut-off point for the claudin-1 index was 2. Lower claudin-1 value was ( <2) & higher claudin-1 value was (>2).
Statistical analysis:
All statistical analyses were carried out using Statistical Package for the Social Science (SPSS) program, Version 16, on a personal computer. The Pearson correlation coefficient, chi square tests & Fisher exact test were used. p-value <_0.05 was considered significant & p-value <0.01 was considered highly significant. Receiver Operator Characteristic (ROC) curve was also used to determine the cut off value of Ki-67 and claudin-1 and their diagnostic performances to discriminate the molecular subtypes of breast ductal carcinoma.
Results
The present retrospective study enrolled 54 cases of female breast ductal carcinoma (NST). Ten cases of apparently normal breast tissue were taken as control. The age of patient with breast (NST) ranged from 29 to 72 years old, median age 50 years old. 6 cases (11.1%) were grade I, 29 cases (53.7%) were grade II and 19 cases (35.2%) were grade III. Regarding TNM staging 18 cases (33.3%) were stage (I), 18 cases (33.3%) were stage II, 9 cases (16.7%) were Stage III and 9 cases (16.7%) were stage IV.
Nottingham prognostic index (NPI) results:
NPI showed a statistically significant correlation with all of age (p<0.05), tumor grade (p<0.01), nuclear grade (p<0.01), tumor size (p-value <0.01), lymph node metastasis (p<0.01), distant metastasis (p<0.05), stage (p<0.01) and lymphovascular invasion (p<0.01).
Ki-67 immunohistochemical staining results:
All ten control cases showed low nuclear expression of Ki-67. Out of the 54 cases of IDC, 37 cases (68.5%) showed high nuclear expression and 17 cases (31.5%) showed low nuclear expression of Ki-67.
High Ki-67 index showed statistically significant correlation with high tumor grade ( p<0.01), nuclear grade (p<0.01), tumor size (p=0.05), LN metastasis (p<0.01), lymphovascular invasion (p<0.01), distant metastasis ( p<0.05), tumor stage (p<0.01) and NPI (p-value <0.01).
High Ki-67 index showed inverse correlation with ER/PR status and positive correlation with Her2 status (p<0.01) and molecular subtypes (p<0.01). The Correlation between Ki-67 index and different pathologic variables and molecular subtypes of study cases was detailed in (Table 1) .
Molecular subtypes results:
Molecular A positive significant statistical correlation was detected between molecular subtypes and tumor grade (p<0.01), nuclear grade (p<0.01), tumor size (p<0.01), lymphovascular invasion (p<0.01), lymph node metastasis (p<0.01), distant metastasis ( p< 0.05), stage (p<0.01) and NPI (p<0.01).
Claudin-1 immunohistochemical staining results:
All ten control cases showed predominantly apicolateral claudin-1 membranous staining pattern of ductal epithelial cells. Out of 54 cases of invasive carcinoma NST (IDC), 26 cases (48%) showed high expression of cluadin1 (membranous & Cytoplasmic staining pattern) and 28 cases (52%) showed low expression of cluadin-1.
High claudin-1 expresion showed a statistically significant correlation with all of tumor grade ( p <0.01), nuclear grade (p<0.01), tumor size (p<0.01), lymphovascular invasion ( p<0.01), lymph node metastasis (p<0.01), distant metastasis (p<0.01), stage (p<0.01) & NPI (p<0.01).
High claudin-1 expression showed inverse correlation with ER/PR status (p<0.01) and positive correlation with molecular subtypes ( p<0.01). The Correlation between claudin-1 and different path-ologic variables and molecular subtypes of study cases was detailed in (Table 1) .
ROC curve results:
The receiver operating characteristics curve analysis showed that the diagnostic performance of both Ki-67 and claudin-1 in discriminating molecular subtypes of breast cancer was accepted. claudin-1 is most sensitive while Ki-67 is most specific in diagnosis of molecular subtypes of invasive carcinoma NST as shown in (Table 3) and Fig. (1) . 
Discussion
Invasive breast carcinoma is the most common malignant tumor in women and the second leading cause of cancer death in women worldwide [13] . In Egypt, in NCI pathology cancer registry, breast cancer is the foremost oncologic problem, contributing to 20% of all cancers and 43% of female cancers [14] .
Breast cancer is a clinically highly heterogeneous disease with distinct pathological and histological features. The current histological classifications may not entirely correlate with the clinical behavior of this disease. Molecular subtypes of breast carcinoma in view of ER, PR, Her2neu, EGFR and basal marker expression status can possibly predict and impact the prognosis and response to hormonal and targeted therapies [15] .
Nottingham Prognostic Index (NPI) is one of the widely accepted clinical tools used to calculate an individual's prognosis. The current study revealed a statistically significant correlation between NPI and age (p<0.05), tumor grade (p<0.01), nuclear grade (p<0.01), tumor size (p<0.01), lymph node metastasis (p<0.01), distant metastasis (pvalue <0.05), stage (p-value <0.01), lymphovascular invasion (p<0.01), and perineural invasion (p<0.05). These results were in parallel yuwith the study of Hearne et al., [16] .
The present study revealed a significant statistical correlation between NPI and hormonal receptors (p<0.05). The study also revealed a significant statistical correlation between NPI and Her2 status (p< 0 . 05 ).
Ki-67 is an immunohistochemical proliferation marker in many types of cancer and has been widely studied among Breast Cancer patients mostly through retrospective studies [17] . In the present study, high Ki-67 index ( ≥ 14%) was significantly correlated with high tumor grade ( p<0.01) as 100% of cases with grade III showed high Ki67 expression. These results were in line with the result of study authored by Yip et al., [18] . However, Madani et al., [19] demonstrated that an insignificant cor-relation between histologic grade and Ki-67 expression (p=0.493). Our results revealed also a positive significant statistical correlation between nuclear grade and Ki-67 expression (p<0.01). That result was in agreement with Tashima et al., [20] .
The present study revealed that there was a positive significant statistical correlation between Ki-67 expression and tumor size (p=0.050), lymph node metastasis (p<0.01) and lymphovascular invasion (p<0.01). As 85.7% of cases with large tumors size >5cm, 100% of cases with (N2 and N3) LN metastasis and 96% in cases with positive LVI showed high Ki-67 expression. These results were in agreement with Inwald et al., [10] . In against results of study done by Madani et al., [19] was using 20% as cut off value for Ki-67 evaluation.
The present study revealed that, there was a positive significant statistical correlation between Ki-67 expression and distant metastasis ( p<0.05) and tumor stage (p<0.01). This is in parallel with the study of Yuan et al., [21] but In contrast to results of work by Soliman et al., [22] which was done on different histologic types of breast cancer (IDC, ILC and mucinous carcinoma). Also we found a positive significant statistical correlation between Ki-67 expression and NPI ( p<0.01). This result agrees with Kurshumliu et al., [23] .
The present results concerning Ki67 may be explained by that activation of Ki-67 leads to ribosomal RNA synthesis and enhance proliferation of tumor cells [24] . Ki-67 directly affects the cell cycle during proliferation phase and could interact with p53, p21, and p27 tumor suppressor genes and modulates cell cycle by affecting the checkpoint of G1 phase [25] .
The current study revealed an inverse significant statistically correlation between Ki-67 and ER/PR status as 90.5% of cases with negative ER and PR receptors showed high Ki-67 expression. This was in agreement with Kontzoglou et al., [17] and Nishimura et al., [26] . This may be explained by that estrogen is a modulator of cellular growth and differentiation. Estrogen mediates most of its functions through two specific intracellular receptors (ERa and ERß) [27] .
The Study of Jensen et al., [28] on ERa and ERß in breast neoplasms found that the presence of ERa in breast cancer epithelium was associated with a decreased expression of the proliferation markers (Ki-67 and cyclin A), whereas ERß expression was associated with elevated levels of these markers.
The present study revealed a positive significant statistical correlation between Ki-67 expression index and Her2 status (p<0.01). This agreed with the studies of Yip et al., [18] , Colozza et al., [29] and Nishimura et al., [30] .
The current study revealed that, there was a significant statistical correlation between Ki-67 expression index and molecular subtypes ( p<0.01) and molecular subtyping can be based on extent of Ki-67 index. These results were in agreement with Wang et al., [12] .
The present study revealed a significant statistical correlation between molecular subtypes of cases and age (p<0.01) as 80% & 79% of luminal A and B tumors respectively were occurred in age more than 50 years old, unlike 70% & 73% of Her2 enriched and Triple negative cases occurred with young age (<50 years old). That result was in line with Liedtke et al., [31] .
The present study revealed a positive significant statistical correlation between molecular subtypes and tumor grade (p<0.01) and nuclear grade (p< 0.01), tumor size (p<0.01), lymphovascular invasion (p<0.01) and lymph node metastasis (p <0.01), and distant metastasis ( p<0.05) & stage (p-value <0.01), NPI (p<0.01) All these results were in parallel to results of study done by Kumar et al., [32] .
Claudin-1 is a tight junction protein which maintains cellular polarity and plays a major role in cell-cell communication and epithelial cell homeostasis. Long considered to be a putative tumor suppressor in human breast cancer, new studies suggest a role much more complex [33] .
The current study demonstrated a positive significant statistical correlation between claudin-1 expression and all of tumor grade (p<0.01), nuclear grade (p<0.01), tumor size (p<0.01), lymphovascular invasion (p<0.01), lymph node metastasis (p<0.01), distant metastasis (p<0.01), stage (p< 0.01) & NPI (p<0.01). These results were in agreement with the results declared by Ko et al., [34] who demonstrated that CLDN high tumors (1,3 & 4) are associated with poor prognostic features.
Claudin-1 role in breast cancer may be explained by its role in Epithelial Mesenchymal Transition (EMT). Claudin-1 has the ability to directly promote (EMT) through its interaction with defined EMT-related transcription factors and signaling pathways [35] . In Breast Cancer, claudin-1 also increased cell motility and invasiveness The present study revealed a negative significant statistical correlation between claudin-1 expression and hormonal receptor expression (ER & PR) status (p<0.01) as 90.5% of cases with negative ER & PR receptors showed high claudin-1 expression while 79% of cases with positive ER & PR showed low claudin-1 expression. These findings are in agreement with Blanchard et al., [37] and Lu et al., [38] .
There have been many hypotheses about the mechanisms responsible for the loss of claudin-1 in ER + breast carcinoma. Some studies have shown that epigenetic factors, in particular transcriptional repression, by Claudin-1 promoter methylation near the CpG islands may be partly responsible for the down regulation of Claudin-1 in ER + tumor tumors [39] .
A statistically significant correlation was approved in this work between claudin-1 expression and molecular subtypes (p<0.01). High expression of Claudin-1 was shown in 39% of cases of luminal B, 90% 0f cases of Her2 Enriched and 91% of cases of triple negative while low expression of claudin-1 was seen in all cases of luminal A, 61% of cases of luminal B. This result was in line with results published by Lu et al., [38] .
The present study revealed that, there was a significant statistical positive correlation between claudin-1 expression and Ki-67 expression in different molecular subtypes of invasive breast carcinoma of NST (p<0.01). This result may be explained by that claudin-1 high tumors are usually associated with ER negative tumors which usually have poor prognostic features and high proliferation rate as in agreement with Ko et al., [34] and Kolokytha et al., [40] .
The study revealed that, by using ROC curve, there was a significant correlation between Ki-67 expression & Claudin-1 expression and different molecular subtypes. We also found that claudin-1 is more sensitive while Ki-67 is more specific in diagnosis of molecular subtypes of invasive carcinoma NS T.
Conclusions:
Claudin-1 overexpression is associated with aggressiveness and poor prognostic factors in breast ductal carcinoma. Claudin-1 overexpression is correlated with high Ki67 proliferative index. Claudin-1 and Ki-67 may have diagnostic role in discrimination between different molecular sub-types of breast ductal carcinoma. Triple negative tumors & Her2 enriched tumors may be considerclaudin-1 in1 high tumors.
